VU0477886 is a positive allosteric modulator of metabotropic glutamate receptor subtype 4 (mGlu4), demonstrating potent activation with an EC50 value of 95 nM and achieving 89% of maximal glutamate response. This compound exhibits favorable pharmacokinetic properties, with a brain-to-plasma distribution ratio (Kp) of 1.3, making it a suitable candidate for neurological research. VU0477886 has shown significant therapeutic effects in preclinical models of Parkinson's disease, highlighting its potential for the treatment of movement disorders.
VU0477886 is a positive allosteric modulator of metabotropic glutamate receptor subtype 4 (mGlu4), demonstrating potent activation with an EC50 value of 95 nM and achieving 89% of maximal glutamate response. This compound exhibits favorable pharmacokinetic properties, with a brain-to-plasma distribution ratio (Kp) of 1.3, making it a suitable candidate for neurological research. VU0477886 has shown significant therapeutic effects in preclinical models of Parkinson's disease, highlighting its potential for the treatment of movement disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
